Overexpression of RBM10 induces osteosarcoma cell apoptosis and inhibits cell proliferation and migration

10Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Osteosarcoma is the most common malignant bone tumor with high incidence in adolescence and poor prognosis. RBM10, a member of RBPs, was reported to be a tumor suppressor in many kinds of cancers. However, the roles of RBM10 in osteosarcoma remain unknown. In this study, we found that overexpression of RBM10 decreased osteosarcoma cell proliferation and colony formation in soft agar, and inhibited osteosarcoma cell migration and invasion. Our results also revealed that RBM10 overexpression induced osteosarcoma cell apoptosis via the inhibition of Bcl-2, the activation of caspase-3, and the transcription and production of TNF-α. Our results indicated that RBM10 acts as a tumor suppressor in osteosarcoma. This could enable to define a new strategy for diagnosis and treatment of patients with osteosarcoma.

Cite

CITATION STYLE

APA

Han, L. P., Wang, C. P., & Han, S. L. (2018). Overexpression of RBM10 induces osteosarcoma cell apoptosis and inhibits cell proliferation and migration. Medecine/Sciences, 34, 81–86. https://doi.org/10.1051/medsci/201834f114

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free